Cover Image
Market Research Report

Autologous Matrix-Induced Chondrogenesis (AMIC)

Published by Global Industry Analysts, Inc. Product code 940695
Published Content info 134 Pages
Delivery time: 1-2 business days
Price
Back to Top
Autologous Matrix-Induced Chondrogenesis (AMIC)
Published: July 1, 2020 Content info: 134 Pages
Description

Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market to Reach $193.2 Million by 2027

Amid the COVID-19 crisis, the global market for Autologous Matrix-Induced Chondrogenesis (AMIC) estimated at US$118.6 Million in the year 2020, is projected to reach a revised size of US$193.2 Million by 2027, growing at a CAGR of 7.2% over the analysis period 2020-2027. Hyaluronic Acid, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$50.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Collagen segment is readjusted to a revised 6.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $35.1 Million, While China is Forecast to Grow at 6.7% CAGR

The Autologous Matrix-Induced Chondrogenesis (AMIC) market in the U.S. is estimated at US$35.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$33.7 Million by the year 2027 trailing a CAGR of 6.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.8% and 5.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.

Polyethylene Glycol (PEG) Segment to Record 9.7% CAGR

In the global Polyethylene Glycol (PEG) segment, USA, Canada, Japan, China and Europe will drive the 9.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$12.1 Million in the year 2020 will reach a projected size of US$23.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$22.3 Million by the year 2027.We bring years of research experience to this 7th edition of our report. The 134-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Anika Therapeutics, Inc.
  • Arthro Kinetics AG
  • B. Braun Melsungen AG
  • BioTissue SA
  • CartiHeal, Inc.
  • Geistlich Pharma AG
  • JRI Orthopaedics Ltd.
  • Matricel GmbH
  • Smith & Nephew PLC
  • Zimmer Biomet Holdings, Inc.
Table of Contents
Product Code: MCP10423

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Autologous Matrix-Induced Chondrogenesis (AMIC) Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Autologous Matrix-Induced Chondrogenesis (AMIC) Global Market Estimates and Forecasts in US$ by Region/Country: 2020-2027
  • TABLE 2: Autologous Matrix-Induced Chondrogenesis (AMIC) Global Retrospective Market Scenario in US$ by Region/Country: 2012-2019
  • TABLE 3: Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Hyaluronic Acid (Segment) World Market by Region/Country in US$: 2020 to 2027
  • TABLE 5: Hyaluronic Acid (Segment) Historic Market Analysis by Region/Country in US$: 2012 to 2019
  • TABLE 6: Hyaluronic Acid (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Collagen (Segment) Potential Growth Markets Worldwide in US$: 2020 to 2027
  • TABLE 8: Collagen (Segment) Historic Market Perspective by Region/Country in US$: 2012 to 2019
  • TABLE 9: Collagen (Segment) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Polyethylene Glycol (PEG) (Segment) Geographic Market Spread Worldwide in US$: 2020 to 2027
  • TABLE 11: Polyethylene Glycol (PEG) (Segment) Region Wise Breakdown of Global Historic Demand in US$: 2012 to 2019
  • TABLE 12: Polyethylene Glycol (PEG) (Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Polylactic-Co-Glycolic Acid (PGLA) (Segment) World Market Estimates and Forecasts by Region/Country in US$: 2020 to 2027
  • TABLE 14: Polylactic-Co-Glycolic Acid (PGLA) (Segment) Market Historic Review by Region/Country in US$: 2012 to 2019
  • TABLE 15: Polylactic-Co-Glycolic Acid (PGLA) (Segment) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Other Segments (Segment) World Market by Region/Country in US$: 2020 to 2027
  • TABLE 17: Other Segments (Segment) Historic Market Analysis by Region/Country in US$: 2012 to 2019
  • TABLE 18: Other Segments (Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 19: United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Estimates and Projections in US$ by Segment: 2020 to 2027
    • TABLE 20: Autologous Matrix-Induced Chondrogenesis (AMIC) Market in the United States by Segment: A Historic Review in US$ for 2012-2019
    • TABLE 21: United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 22: Canadian Autologous Matrix-Induced Chondrogenesis (AMIC) Market Estimates and Forecasts in US$ by Segment: 2020 to 2027
    • TABLE 23: Canadian Autologous Matrix-Induced Chondrogenesis (AMIC) Historic Market Review by Segment in US$: 2012-2019
    • TABLE 24: Autologous Matrix-Induced Chondrogenesis (AMIC) Market in Canada: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027
  • JAPAN
    • TABLE 25: Japanese Market for Autologous Matrix-Induced Chondrogenesis (AMIC): Annual Sales Estimates and Projections in US$ by Segment for the Period 2020-2027
    • TABLE 26: Autologous Matrix-Induced Chondrogenesis (AMIC) Market in Japan: Historic Sales Analysis in US$ by Segment for the Period 2012-2019
    • TABLE 27: Japanese Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share Analysis by Segment: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 28: Chinese Autologous Matrix-Induced Chondrogenesis (AMIC) Market Growth Prospects in US$ by Segment for the Period 2020-2027
    • TABLE 29: Autologous Matrix-Induced Chondrogenesis (AMIC) Historic Market Analysis in China in US$ by Segment: 2012-2019
    • TABLE 30: Chinese Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • EUROPE
    • Market Facts & Figures
    • European Autologous Matrix-Induced Chondrogenesis (AMIC) Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 31: European Autologous Matrix-Induced Chondrogenesis (AMIC) Market Demand Scenario in US$ by Region/Country: 2020-2027
    • TABLE 32: Autologous Matrix-Induced Chondrogenesis (AMIC) Market in Europe: A Historic Market Perspective in US$ by Region/Country for the Period 2012-2019
    • TABLE 33: European Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 34: European Autologous Matrix-Induced Chondrogenesis (AMIC) Market Estimates and Forecasts in US$ by Segment: 2020-2027
    • TABLE 35: Autologous Matrix-Induced Chondrogenesis (AMIC) Market in Europe in US$ by Segment: A Historic Review for the Period 2012-2019
    • TABLE 36: European Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 37: Autologous Matrix-Induced Chondrogenesis (AMIC) Market in France by Segment: Estimates and Projections in US$ for the Period 2020-2027
    • TABLE 38: French Autologous Matrix-Induced Chondrogenesis (AMIC) Historic Market Scenario in US$ by Segment: 2012-2019
    • TABLE 39: French Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share Analysis by Segment: 2012 VS 2020 VS 2027
  • GERMANY
    • TABLE 40: Autologous Matrix-Induced Chondrogenesis (AMIC) Market in Germany: Recent Past, Current and Future Analysis in US$ by Segment for the Period 2020-2027
    • TABLE 41: German Autologous Matrix-Induced Chondrogenesis (AMIC) Historic Market Analysis in US$ by Segment: 2012-2019
    • TABLE 42: German Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 43: Italian Autologous Matrix-Induced Chondrogenesis (AMIC) Market Growth Prospects in US$ by Segment for the Period 2020-2027
    • TABLE 44: Autologous Matrix-Induced Chondrogenesis (AMIC) Historic Market Analysis in Italy in US$ by Segment: 2012-2019
    • TABLE 45: Italian Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • UNITED KINGDOM
    • TABLE 46: United Kingdom Market for Autologous Matrix-Induced Chondrogenesis (AMIC): Annual Sales Estimates and Projections in US$ by Segment for the Period 2020-2027
    • TABLE 47: Autologous Matrix-Induced Chondrogenesis (AMIC) Market in the United Kingdom: Historic Sales Analysis in US$ by Segment for the Period 2012-2019
    • TABLE 48: United Kingdom Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share Analysis by Segment: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 49: Rest of Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Estimates and Forecasts in US$ by Segment: 2020-2027
    • TABLE 50: Autologous Matrix-Induced Chondrogenesis (AMIC) Market in Rest of Europe in US$ by Segment: A Historic Review for the Period 2012-2019
    • TABLE 51: Rest of Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 52: Autologous Matrix-Induced Chondrogenesis (AMIC) Market in Asia-Pacific by Segment: Estimates and Projections in US$ for the Period 2020-2027
    • TABLE 53: Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Historic Market Scenario in US$ by Segment: 2012-2019
    • TABLE 54: Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share Analysis by Segment: 2012 VS 2020 VS 2027
  • REST OF WORLD
    • TABLE 55: Rest of World Autologous Matrix-Induced Chondrogenesis (AMIC) Market Estimates and Forecasts in US$ by Segment: 2020 to 2027
    • TABLE 56: Rest of World Autologous Matrix-Induced Chondrogenesis (AMIC) Historic Market Review by Segment in US$: 2012-2019
    • TABLE 57: Autologous Matrix-Induced Chondrogenesis (AMIC) Market in Rest of World: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027

IV. COMPETITION

  • Total Companies Profiled: 41
Back to Top